Abstract
Introduction: Cataract surgery can be associated
with vision-threatening complications in
patients with diabetes. This study aimed to
assess the functional and anatomic outcomes of
the intravitreal dexamethasone (DEX) implant,
administered at the time as cataract surgery, in
patients with diabetic retinopathy and diabetic
macular edema (DME).
Methods: This was a retrospective, observational,
and single-center study. The primary
endpoint was the mean change in central
macular thickness (CMT) from baseline to
month 1. Secondary endpoints included mean
change in best corrected visual acuity (BCVA)
from baseline to month 1 and 3, mean change
in CMT from baseline to month 3, the photopic
negative response (PhNR) and the b wave of
flash full-field electroretinogram from baseline to month 1, and the incidence of adverse
events.
Results: Twenty-four eyes of 21 patients were
included in the study. The mean (range) age of
patients was 69 (63–87) years and 13 (61.9%)
were men. Mean (standard deviation) CMT significantly
decreased from 447 (134) lm at
baseline to 341 (134) lm at month 1 (mean
difference - 106 ± 134 lm, 95% CI - 183.9 to
- 28.1 lm; p = 0.0087). BCVA significantly
improved from 46 (20) ETDRS letters at baseline
to 59 (22) ETDRS letters at month 1 (mean difference
13 ± 21 letters, 95% CI 0.8–25.2 letters;
p = 0.0375). Regarding electrophysiology, there
was a statistically significant reduction in mean
PhNR from 5.24 (1.67) lV at baseline to 3.73
(1.19) lV at month 1 (mean difference
- 1.51 ± 0.42 lV, 95% CI - 2.4 to - 0.7 lV,
p = 0.0008); whereas b wave amplitude did not
change (12.69 ± 6.89 lV at baseline versus
12.29 ± 6.30 lV at month 1; p = 0.8347). Four
(16.7%) eyes developed ocular hypertension
over the course of follow-up, which was successfully
controlled with topical hypotensive
medication.
Conclusion: Perioperative DEX implant significantly
improved both anatomic and functional
outcomes in patients with DME who underwent
cataract surgery.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | N/A-N/A |
| Rivista | Advances in Therapy |
| Volume | 2020 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2020 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
Keywords
- cataract, diabetes, diabetic macular edema, diabetic retinopathy, electrophysiology, macular thickness, personalized medicine, visual acuity
Fingerprint
Entra nei temi di ricerca di 'Combined Intravitreal Dexamethasone Implant and Cataract Surgery in Patients with Diabetic Retinopathy: Effect on Retinal Morphology and Function'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver